Cinclus Pharma Holding AB (OSTO:CINPHA) Buildings And Improvements : kr0.00 Mil (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Cinclus Pharma Holding AB Buildings And Improvements?

Cinclus Pharma Holding AB Buildings And Improvements Historical Data

The historical data trend for Cinclus Pharma Holding AB's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cinclus Pharma Holding AB Buildings And Improvements Chart

Cinclus Pharma Holding AB Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Buildings And Improvements

Cinclus Pharma Holding AB Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Buildings And Improvements	Get a 7-Day Free Trial						-	-	-	-	-

Cinclus Pharma Holding AB Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Cinclus Pharma Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cinclus Pharma Holding AB (OSTO:CINPHA) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

J8P:Germany

Address

Kungsbron 1, Stockholm, SWE, SE-111 22

Website

https://www.cincluspharma.com

Cinclus Pharma Holding AB is a clinical stage pharmaceutical company developing a drug for the treatment of erosive gastroesophageal reflux diseases, and a dual therapy treatment with an antibiotic targeting Helicobacter pylori which is a bacteria that occurs in the gastric and duodenal mucosa. The Company's main target population is patients suffering from severe eGERD, where there is a lack of satisfactory treatment options.

Cinclus Pharma Holding AB Headlines

No Headlines